U.S. Justice Department subpoenas Taro over generic drug pricing
September 11, 2016 at 13:43 PM EDT
WASHINGTON, Sept 11 (Reuters) - Taro Pharmaceutical Industries Ltd. and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed late on Friday.